Volker Kaechele Selected Research

Disease Progression

1/2008

Response to reintroduction of cetuximab in 5 patients with advanced, chemotherapy-resistant, colorectal cancer without progressive disease following first-line therapy with a cetuximab-containing regimen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Volker Kaechele Research Topics

Disease

3	Neoplasms (Cancer) 10/2012 - 01/2008
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 01/2008
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Exanthema (Rash) 10/2012
1	Adenocarcinoma 05/2010
1	Disease Progression 01/2008

Drug/Important Bio-Agent (IBA)

1	trifluridine tipiracil drug combinationIBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 10/2012
1	HLA-A Antigens (HLA-A)IBA 10/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2010
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2010
1	Cetuximab (Erbitux)FDA Link 01/2008

Therapy/Procedure

3	Therapeutics 01/2018 - 01/2008
1	Drug Therapy (Chemotherapy) 01/2008